Literature DB >> 11292105

A model for predicting life expectancy of children with cystic fibrosis.

P Aurora1, A Wade, P Whitmore, B Whitehead.   

Abstract

In this study the authors aimed to produce a model for predicting the life expectancy of children with severe cystic fibrosis (CF) lung disease. The survival of 181 children with severe CF lung disease referred for transplantation assessment 1988-1998 (mean age 11.5 yrs, median survival without transplant 1.9 yrs from date of assessment) were studied. Proportional hazards modelling was used to identify assessment measurements that are of value in predicting longevity. The resultant model included low height predicted forced expiratory volume in one second (FEV1), low minimum oxygen saturation (Sa,O2min) during a 12-min walk, high age adjusted resting heart rate, young age, female sex, low plasma albumin, and low blood haemoglobin as predictors for poor prognosis. Extrapolation from the model suggests that a 12-yr old male child with an FEV1 of 30% pred and a Sa,O2min of 85% has a 44% risk of death within 2 yrs (95% confidence interval (CI) 35-54%), whilst a female child with the same measurements has a 63% risk of death (95% CI 52-73%) within the same period. The model produced may be of value in predicting the life expectancy of children with severe cystic fibrosis lung disease and in optimizing the timing of lung transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11292105     DOI: 10.1034/j.1399-3003.2000.16f06.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Exercise testing in children with cystic fibrosis.

Authors:  Diane Rogers; S Ammani Prasad; Iolo Doull
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  Current status of paediatric heart, lung, and heart-lung transplantation.

Authors:  M Burch; P Aurora
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

Review 3.  Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Authors:  Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz
Journal:  J Cyst Fibros       Date:  2019-03-27       Impact factor: 5.482

4.  Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis.

Authors:  E Hatziagorou; V Avramidou; F Kirvassilis; J Tsanakas
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

5.  Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship.

Authors:  M Carlsson; A G Sjöholm; L Eriksson; S Thiel; J C Jensenius; M Segelmark; L Truedsson
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

6.  Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests.

Authors:  Sooky Lum; Per Gustafsson; Henrik Ljungberg; Georg Hülskamp; Andrew Bush; Siobhán B Carr; Rosemary Castle; Ah-Fong Hoo; John Price; Sarath Ranganathan; John Stroobant; Angie Wade; Colin Wallis; Hilary Wyatt; Janet Stocks
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

7.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12

8.  Pediatric lung transplantation for cystic fibrosis.

Authors:  Theodore G Liou; Barbara C Cahill
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

9.  Determinants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: a multicenter study.

Authors:  Joëlle Texereau; Dany Jamal; Gérald Choukroun; Pierre-Régis Burgel; Jean-Luc Diehl; Antoine Rabbat; Philippe Loirat; Antoine Parrot; Alexandre Duguet; Joël Coste; Daniel Dusser; Dominique Hubert; Jean-Paul Mira
Journal:  Respir Res       Date:  2006-01-26

10.  Practical guidelines: lung transplantation in patients with cystic fibrosis.

Authors:  T O Hirche; C Knoop; H Hebestreit; D Shimmin; A Solé; J S Elborn; H Ellemunter; P Aurora; M Hogardt; T O F Wagner
Journal:  Pulm Med       Date:  2014-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.